(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CDKN2B mRNA] CTD PMID:31150632 1,2-dichloroethane increases expression ISO Cdkn2b (Mus musculus) 6480464 ethylene dichloride results in increased expression of CDKN2B mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO Cdkn2b (Mus musculus) 6480464 [1 more ... CTD PMID:22206623 and PMID:26388957 1,2-dimethylhydrazine decreases expression ISO Cdkn2b (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CDKN2B mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CDKN2B mRNA CTD PMID:30723492 17beta-estradiol multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Estradiol co-treated with EGF protein] results in decreased expression of CDKN2B mRNA more ... CTD PMID:20660070 more ... 17beta-estradiol increases expression ISO CDKN2B (Homo sapiens) 6480464 Estradiol results in increased expression of CDKN2B mRNA CTD PMID:23094148 17beta-estradiol decreases expression ISO CDKN2B (Homo sapiens) 6480464 Estradiol results in decreased expression of CDKN2B mRNA CTD PMID:24758408 and PMID:31614463 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO CDKN2B (Homo sapiens) 6480464 2 more ... CTD PMID:26988655 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO CDKN2B (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CDKN2B mRNA and Tetrachlorodibenzodioxin results in decreased expression of CDKN2B protein CTD PMID:17070097 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CDKN2B mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cdkn2b (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CDKN2B mRNA CTD PMID:16611356 and PMID:20805476 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO CDKN2B (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of CDKN2B mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cdkn2b (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CDKN2B mRNA CTD PMID:19770486 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:32109520 2-acetamidofluorene increases expression ISO Cdkn2b (Mus musculus) 6480464 2-Acetylaminofluorene results in increased expression of CDKN2B mRNA CTD PMID:17317680 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of CDKN2B mRNA CTD PMID:22213190 2-hydroxypropanoic acid increases expression ISO CDKN2B (Homo sapiens) 6480464 Lactic Acid results in increased expression of CDKN2B mRNA CTD PMID:30851411 4,4'-diaminodiphenylmethane decreases expression ISO Cdkn2b (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of CDKN2B mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO Cdkn2b (Mus musculus) 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CDKN2B mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO Cdkn2b (Mus musculus) 6480464 Fenretinide results in decreased expression of CDKN2B mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine decreases methylation ISO CDKN2B (Homo sapiens) 6480464 Decitabine results in decreased methylation of CDKN2B gene and Decitabine results in decreased methylation of CDKN2B promoter CTD PMID:17294728 and PMID:19194470 5-aza-2'-deoxycytidine affects expression ISO CDKN2B (Homo sapiens) 6480464 Decitabine affects the expression of CDKN2B mRNA and Decitabine affects the expression of CDKN2B protein CTD PMID:16882708 and PMID:17056112 5-aza-2'-deoxycytidine increases expression ISO Cdkn2b (Mus musculus) 6480464 Decitabine results in increased expression of CDKN2B mRNA CTD PMID:27915011 5-aza-2'-deoxycytidine multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Decitabine affects the methylation of CDKN2B promoter] which affects the expression of CDKN2B mRNA and Decitabine promotes the reaction [trichostatin A results in increased expression of CDKN2B mRNA] CTD PMID:18704418 and PMID:18718068 5-aza-2'-deoxycytidine increases expression ISO CDKN2B (Homo sapiens) 6480464 Decitabine results in increased expression of CDKN2B mRNA CTD PMID:17679729 and PMID:17785578 5-aza-2'-deoxycytidine affects methylation ISO CDKN2B (Homo sapiens) 6480464 Decitabine affects the methylation of CDKN2B gene CTD PMID:17056112 5-azacytidine decreases methylation ISO CDKN2B (Homo sapiens) 6480464 Azacitidine results in decreased methylation of CDKN2B promoter CTD PMID:19194470 5-azacytidine multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [metacept-1 co-treated with Azacitidine] results in increased expression of CDKN2B CTD PMID:19148494 5-azacytidine affects response to substance ISO CDKN2B (Homo sapiens) 6480464 CDKN2B promoter modified form affects the susceptibility to Azacitidine CTD PMID:17611569 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CDKN2B mRNA CTD PMID:30047161 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:19480007 acetamide increases expression EXP 6480464 acetamide results in increased expression of CDKN2B mRNA CTD PMID:31881176 afimoxifene multiple interactions ISO CDKN2B (Homo sapiens) 6480464 afimoxifene inhibits the reaction [Estrogens results in decreased expression of CDKN2B mRNA] CTD PMID:21233418 aflatoxin B1 affects expression ISO CDKN2B (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of CDKN2B protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CDKN2B mRNA CTD PMID:25378103 aflatoxin B1 increases expression ISO CDKN2B (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of CDKN2B mRNA CTD PMID:21641981 and PMID:27153756 all-trans-retinoic acid increases expression ISO CDKN2B (Homo sapiens) 6480464 Tretinoin results in increased expression of CDKN2B mRNA CTD PMID:17138961 more ... all-trans-retinoic acid multiple interactions ISO Cdkn2b (Mus musculus) 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of CDKN2B mRNA and [bisphenol F co-treated with Tretinoin] results in decreased expression of CDKN2B mRNA CTD PMID:30951980 amitrole increases expression EXP 6480464 Amitrole results in increased expression of CDKN2B mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CDKN2B mRNA CTD PMID:16483693 antimonite multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CDKN2B mRNA CTD PMID:32076005 aristolochic acid A increases expression ISO CDKN2B (Homo sapiens) 6480464 aristolochic acid I results in increased expression of CDKN2B mRNA CTD PMID:33212167 arotinoid acid multiple interactions ISO CDKN2B (Homo sapiens) 6480464 4-(2-(5 more ... CTD PMID:12421932 arsane decreases expression ISO CDKN2B (Homo sapiens) 6480464 Arsenic results in decreased expression of CDKN2B mRNA CTD PMID:19945496 arsane multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CDKN2B mRNA CTD PMID:32525701 arsenic atom decreases expression ISO CDKN2B (Homo sapiens) 6480464 Arsenic results in decreased expression of CDKN2B mRNA CTD PMID:19945496 arsenic atom multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CDKN2B mRNA CTD PMID:32525701 arsenite(3-) increases expression ISO Cdkn2b (Mus musculus) 6480464 arsenite results in increased expression of CDKN2B mRNA CTD PMID:33010264 arsenite(3-) multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of CDKN2B mRNA CTD PMID:32076005 arsenous acid multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Arsenic Trioxide results in decreased methylation of CDKN2B promoter] which results in increased expression of CDKN2B mRNA and [Valproic Acid co-treated with Arsenic Trioxide] results in increased expression of CDKN2B mRNA CTD PMID:19099629 and PMID:20596618 arsenous acid increases expression ISO CDKN2B (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of CDKN2B mRNA CTD PMID:11877046 more ... arsenous acid decreases methylation ISO CDKN2B (Homo sapiens) 6480464 Arsenic Trioxide results in decreased methylation of CDKN2B gene CTD PMID:12679007 and PMID:17294728 auraptene affects expression ISO CDKN2B (Homo sapiens) 6480464 aurapten affects the expression of CDKN2B mRNA CTD PMID:23320178 avobenzone decreases expression ISO CDKN2B (Homo sapiens) 6480464 avobenzone results in decreased expression of CDKN2B mRNA CTD PMID:31016361 azathioprine increases expression ISO CDKN2B (Homo sapiens) 6480464 Azathioprine results in increased expression of CDKN2B mRNA CTD PMID:22623647 benzene multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Benzene results in increased methylation of CDKN2B promoter] which results in decreased expression of CDKN2B mRNA CTD PMID:20044985 benzene decreases expression ISO CDKN2B (Homo sapiens) 6480464 Benzene results in decreased expression of CDKN2B mRNA CTD PMID:20044985 benzo[a]pyrene increases expression ISO CDKN2B (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of CDKN2B mRNA CTD PMID:20064835 more ... benzo[a]pyrene multiple interactions ISO Cdkn2b (Mus musculus) 6480464 [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of CDKN2B mRNA CTD PMID:25820237 benzo[a]pyrene increases expression ISO Cdkn2b (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CDKN2B mRNA CTD PMID:19770486 and PMID:22228805 benzo[a]pyrene diol epoxide I increases expression ISO CDKN2B (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDKN2B mRNA and isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDKN2B mRNA] CTD PMID:21295105 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of CDKN2B mRNA CTD PMID:22687991 bis(2-chloroethyl) sulfide increases expression ISO CDKN2B (Homo sapiens) 6480464 Mustard Gas results in increased expression of CDKN2B mRNA CTD PMID:25102026 and PMID:33491125 bis(2-ethylhexyl) phthalate increases expression ISO CDKN2B (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of CDKN2B mRNA CTD PMID:31163220 bisphenol A increases expression ISO Cdkn2b (Mus musculus) 6480464 bisphenol A results in increased expression of CDKN2B mRNA CTD PMID:21932408 and PMID:30951980 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CDKN2B mRNA CTD PMID:30816183 and PMID:32528016 bisphenol A multiple interactions ISO Cdkn2b (Mus musculus) 6480464 [bisphenol A co-treated with Tretinoin] results in decreased expression of CDKN2B mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of CDKN2B gene CTD PMID:28505145 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CDKN2B mRNA CTD PMID:25181051 bisphenol F increases expression ISO Cdkn2b (Mus musculus) 6480464 bisphenol F results in increased expression of CDKN2B mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO Cdkn2b (Mus musculus) 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of CDKN2B mRNA CTD PMID:30951980 cadmium atom increases expression ISO Cdkn2b (Mus musculus) 6480464 Cadmium results in increased expression of CDKN2B mRNA CTD PMID:24067728 cadmium dichloride increases expression ISO CDKN2B (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of CDKN2B mRNA CTD PMID:26525392 and PMID:32512071 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CDKN2B mRNA CTD PMID:31077537 and PMID:33453195 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of CDKN2B mRNA CTD PMID:31077537 calciol increases expression ISO Cdkn2b (Mus musculus) 6480464 Cholecalciferol results in increased expression of CDKN2B mRNA CTD PMID:16508948 calcitriol increases expression ISO CDKN2B (Homo sapiens) 6480464 Calcitriol results in increased expression of CDKN2B mRNA CTD PMID:21592394 calcitriol multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of CDKN2B mRNA CTD PMID:21592394 cannabidiol increases expression ISO Cdkn2b (Mus musculus) 6480464 Cannabidiol results in increased expression of CDKN2B mRNA CTD PMID:21542829 cannabidiol increases expression ISO CDKN2B (Homo sapiens) 6480464 Cannabidiol results in increased expression of CDKN2B mRNA CTD PMID:36519830 cantharidin affects expression ISO CDKN2B (Homo sapiens) 6480464 Cantharidin affects the expression of CDKN2B mRNA CTD PMID:31945315 carbamazepine affects expression ISO CDKN2B (Homo sapiens) 6480464 Carbamazepine affects the expression of CDKN2B mRNA CTD PMID:25979313 carbon nanotube increases expression ISO Cdkn2b (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of CDKN2B mRNA CTD PMID:25554681 chromium(6+) increases expression EXP 6480464 chromium hexavalent ion results in increased expression of CDKN2B protein CTD PMID:21621607 chromium(6+) multiple interactions ISO Cdkn2b (Mus musculus) 6480464 [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of CDKN2B mRNA CTD PMID:25820237 cisplatin multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Cisplatin co-treated with Quercetin] results in increased expression of CDKN2B mRNA CTD PMID:27514524 copper atom multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of CDKN2B mRNA CTD PMID:30911355 copper(0) multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of CDKN2B mRNA CTD PMID:30911355 coumestrol multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol decreases expression ISO CDKN2B (Homo sapiens) 6480464 Coumestrol results in decreased expression of CDKN2B mRNA CTD PMID:19167446 crocidolite asbestos affects expression ISO CDKN2B (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of CDKN2B mRNA CTD PMID:25757056 crocidolite asbestos decreases expression ISO CDKN2B (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of CDKN2B mRNA CTD PMID:29523930 cyclosporin A increases expression ISO CDKN2B (Homo sapiens) 6480464 Cyclosporine results in increased expression of CDKN2B mRNA CTD PMID:21632981 and PMID:25562108 cylindrospermopsin increases expression ISO CDKN2B (Homo sapiens) 6480464 cylindrospermopsin results in increased expression of CDKN2B mRNA CTD PMID:23726867 cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of CDKN2B mRNA CTD PMID:22528246 daunorubicin increases expression ISO CDKN2B (Homo sapiens) 6480464 Daunorubicin results in increased expression of CDKN2B mRNA CTD PMID:12656675 diallyl disulfide multiple interactions EXP 6480464 [Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of CDKN2B mRNA CTD PMID:31077537 diarsenic trioxide multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Arsenic Trioxide results in decreased methylation of CDKN2B promoter] which results in increased expression of CDKN2B mRNA and [Valproic Acid co-treated with Arsenic Trioxide] results in increased expression of CDKN2B mRNA CTD PMID:19099629 and PMID:20596618 diarsenic trioxide decreases methylation ISO CDKN2B (Homo sapiens) 6480464 Arsenic Trioxide results in decreased methylation of CDKN2B gene CTD PMID:12679007 and PMID:17294728 diarsenic trioxide increases expression ISO CDKN2B (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of CDKN2B mRNA CTD PMID:11877046 more ... dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of CDKN2B mRNA CTD PMID:18636392 dimethylarsinic acid decreases expression EXP 6480464 Cacodylic Acid results in decreased expression of CDKN2B mRNA CTD PMID:17720352 dimethylarsinous acid decreases expression ISO CDKN2B (Homo sapiens) 6480464 dimethylarsinous acid results in decreased expression of CDKN2B mRNA CTD PMID:19945496 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CDKN2B mRNA CTD PMID:32076005 disodium selenite increases expression ISO CDKN2B (Homo sapiens) 6480464 Sodium Selenite results in increased expression of CDKN2B mRNA CTD PMID:16705456 dorsomorphin multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN2B mRNA CTD PMID:27188386 doxorubicin decreases expression ISO CDKN2B (Homo sapiens) 6480464 Doxorubicin results in decreased expression of CDKN2B mRNA CTD PMID:29803840 doxorubicin increases expression ISO CDKN2B (Homo sapiens) 6480464 Doxorubicin results in increased expression of CDKN2B mRNA CTD PMID:30031762 endosulfan increases expression ISO CDKN2B (Homo sapiens) 6480464 Endosulfan results in increased expression of CDKN2B mRNA CTD PMID:26615145 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of CDKN2B mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CDKN2B mRNA CTD PMID:19167446 entinostat increases expression ISO CDKN2B (Homo sapiens) 6480464 entinostat results in increased expression of CDKN2B mRNA CTD PMID:27188386 fenbendazole increases expression EXP 6480464 Fenbendazole results in increased expression of CDKN2B mRNA CTD PMID:23411599 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of CDKN2B mRNA CTD PMID:18035473 fluoxetine increases expression ISO Cdkn2b (Mus musculus) 6480464 Fluoxetine results in increased expression of CDKN2B mRNA CTD PMID:21497159 folic acid multiple interactions ISO Cdkn2b (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CDKN2B mRNA CTD PMID:22206623 formaldehyde increases expression ISO CDKN2B (Homo sapiens) 6480464 Formaldehyde results in increased expression of CDKN2B mRNA CTD PMID:20655997 formaldehyde decreases expression EXP 6480464 Formaldehyde results in decreased expression of CDKN2B mRNA CTD PMID:12679049 fumonisin B1 increases expression ISO Cdkn2b (Mus musculus) 6480464 fumonisin B1 results in increased expression of CDKN2B mRNA CTD PMID:16221962 furan increases expression EXP 6480464 furan results in increased expression of CDKN2B mRNA CTD PMID:20562052 more ... gefitinib increases expression ISO CDKN2B (Homo sapiens) 6480464 gefitinib results in increased expression of CDKN2B mRNA and gefitinib results in increased expression of CDKN2B protein CTD PMID:17513607 genistein increases expression ISO CDKN2B (Homo sapiens) 6480464 Genistein results in increased expression of CDKN2B mRNA CTD PMID:22228119 genistein increases expression ISO Cdkn2b (Mus musculus) 6480464 Genistein results in increased expression of CDKN2B mRNA CTD PMID:32186404 GW 3965 increases expression ISO CDKN2B (Homo sapiens) 6480464 GW 3965 results in increased expression of CDKN2B mRNA CTD PMID:31437187 GW 4064 decreases expression ISO CDKN2B (Homo sapiens) 6480464 GW 4064 results in decreased expression of CDKN2B mRNA CTD PMID:31437187 harmine decreases expression ISO CDKN2B (Homo sapiens) 6480464 Harmine results in decreased expression of CDKN2B mRNA CTD PMID:25751815 hydrogen peroxide decreases expression ISO CDKN2B (Homo sapiens) 6480464 Hydrogen Peroxide results in decreased expression of CDKN2B mRNA CTD PMID:12419474 hydrogen peroxide decreases expression ISO Cdkn2b (Mus musculus) 6480464 Hydrogen Peroxide results in decreased expression of CDKN2B mRNA CTD PMID:14729362 hydroxyurea increases expression ISO Cdkn2b (Mus musculus) 6480464 Hydroxyurea results in increased expression of CDKN2B mRNA CTD PMID:27208086 indole-3-methanol increases expression ISO CDKN2B (Homo sapiens) 6480464 indole-3-carbinol results in increased expression of CDKN2B CTD PMID:16082211 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of CDKN2B mRNA CTD PMID:33862172 linalool increases expression ISO CDKN2B (Homo sapiens) 6480464 linalool results in increased expression of CDKN2B mRNA CTD PMID:19922762 lithium chloride increases expression ISO CDKN2B (Homo sapiens) 6480464 Lithium Chloride results in increased expression of CDKN2B mRNA CTD PMID:23527032 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of CDKN2B mRNA CTD PMID:28801915 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of CDKN2B mRNA CTD PMID:16507785 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of CDKN2B mRNA CTD PMID:15644446 methylparaben decreases expression ISO CDKN2B (Homo sapiens) 6480464 methylparaben results in decreased expression of CDKN2B mRNA CTD PMID:31745603 mono(2-ethylhexyl) phthalate multiple interactions ISO Cdkn2b (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CDKN2B mRNA CTD PMID:31884101 monobenzyl phthalate multiple interactions ISO Cdkn2b (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CDKN2B mRNA CTD PMID:31884101 monoethyl phthalate multiple interactions ISO Cdkn2b (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CDKN2B mRNA CTD PMID:31884101 monosodium L-glutamate multiple interactions ISO Cdkn2b (Mus musculus) 6480464 [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of CDKN2B mRNA CTD PMID:19001666 monosodium L-glutamate increases expression EXP 6480464 Sodium Glutamate results in increased expression of CDKN2B mRNA CTD PMID:28954212 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO CDKN2B (Homo sapiens) 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [TGFB1 protein results in increased expression of CDKN2B mRNA] CTD PMID:16361081 N-nitrosodiethylamine decreases expression ISO Cdkn2b (Mus musculus) 6480464 Diethylnitrosamine results in decreased expression of CDKN2B mRNA CTD PMID:18691550 N-nitrosodiethylamine increases expression ISO Cdkn2b (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of CDKN2B mRNA CTD PMID:24535843 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDKN2B mRNA and isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDKN2B mRNA] CTD PMID:21295105 N-nitrosodiethylamine multiple interactions ISO Cdkn2b (Mus musculus) 6480464 IKBKB protein inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN2B mRNA] CTD PMID:18691550 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of CDKN2B mRNA CTD PMID:15138612 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of CDKN2B mRNA CTD PMID:22546817 ochratoxin A decreases acetylation ISO CDKN2B (Homo sapiens) 6480464 ochratoxin A results in decreased acetylation of CDKN2B promoter CTD PMID:29098329 ochratoxin A decreases expression ISO CDKN2B (Homo sapiens) 6480464 ochratoxin A results in decreased expression of CDKN2B mRNA CTD PMID:30763683 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of CDKN2B mRNA CTD PMID:18636392 palbociclib multiple interactions ISO CDKN2B (Homo sapiens) 6480464 2-(5-benzo(1 and 3)dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrochloride inhibits the reaction [palbociclib results in increased expression of CDKN2B protein] CTD PMID:22869556 palbociclib decreases response to substance ISO CDKN2B (Homo sapiens) 6480464 CDKN2B protein results in decreased susceptibility to palbociclib CTD PMID:22711607 palbociclib increases expression ISO CDKN2B (Homo sapiens) 6480464 palbociclib results in increased expression of CDKN2B protein CTD PMID:22869556 paracetamol affects expression ISO CDKN2B (Homo sapiens) 6480464 Acetaminophen affects the expression of CDKN2B mRNA CTD PMID:25458485 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CDKN2B mRNA CTD PMID:33387578 paracetamol increases expression ISO CDKN2B (Homo sapiens) 6480464 Acetaminophen results in increased expression of CDKN2B mRNA CTD PMID:29067470 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of CDKN2B mRNA CTD PMID:32680482 pentachlorophenol increases expression EXP 6480464 Pentachlorophenol results in increased expression of CDKN2B mRNA CTD PMID:19442831 phenylmercury acetate increases expression ISO CDKN2B (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of CDKN2B mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN2B mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate multiple interactions ISO CDKN2B (Homo sapiens) 6480464 4-(2-(5 more ... CTD PMID:12421932 pirinixic acid multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CDKN2B mRNA CTD PMID:19710929 pirinixic acid multiple interactions ISO Cdkn2b (Mus musculus) 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of CDKN2B mRNA] CTD PMID:16221962 pirinixic acid increases expression ISO Cdkn2b (Mus musculus) 6480464 pirinixic acid results in increased expression of CDKN2B mRNA CTD PMID:16221962 pirinixic acid decreases expression ISO Cdkn2b (Mus musculus) 6480464 pirinixic acid results in decreased expression of CDKN2B mRNA CTD PMID:17426115 prednisone increases expression ISO CDKN2B (Homo sapiens) 6480464 Prednisone results in increased expression of CDKN2B protein CTD PMID:15034294 progesterone multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of CDKN2B mRNA CTD PMID:20660070 quercetin multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Cisplatin co-treated with Quercetin] results in increased expression of CDKN2B mRNA CTD PMID:27514524 quercetin increases expression ISO CDKN2B (Homo sapiens) 6480464 Quercetin results in increased expression of CDKN2B mRNA CTD PMID:21632981 and PMID:27514524 quercetin 3-O-beta-D-glucofuranoside multiple interactions EXP 6480464 isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDKN2B mRNA] CTD PMID:21295105 quercetin 3-O-beta-D-glucopyranoside multiple interactions EXP 6480464 isoquercitrin inhibits the reaction [[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDKN2B mRNA] CTD PMID:21295105 rac-lactic acid increases expression ISO CDKN2B (Homo sapiens) 6480464 Lactic Acid results in increased expression of CDKN2B mRNA CTD PMID:30851411 resveratrol multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of CDKN2B mRNA CTD PMID:19167446 resveratrol increases expression ISO CDKN2B (Homo sapiens) 6480464 resveratrol results in increased expression of CDKN2B mRNA CTD PMID:25888808 rifampicin multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of CDKN2B mRNA CTD PMID:21127053 ritonavir increases expression ISO CDKN2B (Homo sapiens) 6480464 Ritonavir results in increased expression of CDKN2B mRNA CTD PMID:19386116 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO CDKN2B (Homo sapiens) 6480464 S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of CDKN2B mRNA CTD PMID:33725128 SB 431542 multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN2B mRNA CTD PMID:27188386 sodium arsenate multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CDKN2B mRNA CTD PMID:32525701 sodium arsenite decreases expression ISO Cdkn2b (Mus musculus) 6480464 sodium arsenite results in decreased expression of CDKN2B mRNA CTD PMID:16014739 sodium arsenite decreases expression ISO CDKN2B (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CDKN2B mRNA CTD PMID:34032870 sodium arsenite multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of CDKN2B mRNA CTD PMID:32076005 sodium arsenite affects expression ISO Cdkn2b (Mus musculus) 6480464 sodium arsenite affects the expression of CDKN2B mRNA CTD PMID:16507464 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of CDKN2B mRNA CTD PMID:12325037 sorafenib increases expression ISO Cdkn2b (Mus musculus) 6480464 sorafenib results in increased expression of CDKN2B protein CTD PMID:19139124 sterigmatocystin affects expression EXP 6480464 Sterigmatocystin affects the expression of CDKN2B mRNA CTD PMID:34126181 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of CDKN2B mRNA CTD PMID:30047161 sunitinib decreases expression ISO CDKN2B (Homo sapiens) 6480464 Sunitinib results in decreased expression of CDKN2B mRNA CTD PMID:31533062 tert-butyl hydroperoxide decreases expression ISO CDKN2B (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of CDKN2B mRNA CTD PMID:12419474 tert-butyl hydroperoxide decreases expression ISO Cdkn2b (Mus musculus) 6480464 tert-Butylhydroperoxide results in decreased expression of CDKN2B mRNA CTD PMID:14729362 testosterone multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of CDKN2B mRNA CTD PMID:21592394 testosterone increases expression ISO CDKN2B (Homo sapiens) 6480464 Testosterone results in increased expression of CDKN2B mRNA CTD PMID:21592394 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CDKN2B mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CDKN2B mRNA] CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CDKN2B mRNA CTD PMID:22659510 more ... titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of CDKN2B mRNA CTD PMID:30012374 tributylstannane multiple interactions ISO CDKN2B (Homo sapiens) 6480464 2-(2 and 6-dimethylmorpholin-4-yl)-N-(5-(6-morpholin-4-yl-4-oxo-4H-pyran-2-yl)-9H-thioxanthen-2-yl)acetamide inhibits the reaction [tributyltin results in increased expression of CDKN2B protein] CTD PMID:36319700 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CDKN2B mRNA CTD PMID:33387578 trichostatin A multiple interactions ISO CDKN2B (Homo sapiens) 6480464 decitabine promotes the reaction [trichostatin A results in increased expression of CDKN2B mRNA] CTD PMID:18718068 trichostatin A increases expression ISO CDKN2B (Homo sapiens) 6480464 trichostatin A results in increased expression of CDKN2B mRNA CTD PMID:18718068 triclosan decreases expression ISO CDKN2B (Homo sapiens) 6480464 Triclosan results in decreased expression of CDKN2B mRNA CTD PMID:30510588 urethane decreases expression ISO Cdkn2b (Mus musculus) 6480464 Urethane results in decreased expression of CDKN2B mRNA CTD PMID:12117781 urethane increases expression ISO CDKN2B (Homo sapiens) 6480464 Urethane results in increased expression of CDKN2B mRNA CTD PMID:28818685 valproic acid multiple interactions ISO CDKN2B (Homo sapiens) 6480464 [Valproic Acid co-treated with arsenic trioxide] results in increased expression of CDKN2B mRNA CTD PMID:19099629 valproic acid increases expression ISO CDKN2B (Homo sapiens) 6480464 Valproic Acid results in increased expression of CDKN2B mRNA and Valproic Acid results in increased expression of CDKN2B protein CTD PMID:22083351 more ... vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of CDKN2B gene CTD PMID:31682807 vorinostat increases expression ISO CDKN2B (Homo sapiens) 6480464 vorinostat results in increased expression of CDKN2B mRNA and vorinostat results in increased expression of CDKN2B protein CTD PMID:22083351 zinc dichloride decreases expression ISO CDKN2B (Homo sapiens) 6480464 zinc chloride results in decreased expression of CDKN2B mRNA CTD PMID:21540303 zoledronic acid increases expression ISO CDKN2B (Homo sapiens) 6480464 zoledronic acid results in increased expression of CDKN2B mRNA CTD PMID:24714768